According to FutureWise analysis the atherectomy devices market in 2025 is US$0.92 billion, and is expected to reach US$ 1.68 billion by 2033 at a CAGR of 7.8%. The market's expansion can be linked to a growing prevalence of peripheral artery disease (PAD) and a heightened preference for minimally invasive procedures. Additionally, advancements in technology—such as directional, rotational, and laser atherectomy systems—are improving both procedural efficiency and patient outcomes, contributing to the expansion of the market.

Atherectomy devices are advanced medical instruments specifically designed for minimally invasive procedures aimed at treating atherosclerosis, a condition marked by the accumulation of plaque in the arteries. This plaque buildup can impede blood flow, potentially leading to significant cardiovascular issues. Atherectomy devices operate by removing or modifying this plaque from the arterial walls, thereby restoring blood flow and enhancing vascular health. These devices are particularly valuable in situations where traditional treatments, such as balloon angioplasty or stenting, may not be effective, especially in cases with heavily calcified or complex lesions.

The main purpose of atherectomy devices is to physically excise or vaporize plaque, which is composed of cholesterol, calcium, and fibrous tissue, from the interior of the arteries. In contrast to angioplasty, which compresses plaque against the arterial walls, atherectomy actively removes or ablates the plaque. This method minimizes the risk of vessel trauma and generally leads to better long-term results. Atherectomy is commonly utilized in both coronary and peripheral arteries to treat conditions such as coronary artery disease and peripheral artery disease.

Various types of atherectomy devices employ different mechanisms for plaque removal. Directional atherectomy devices utilize a rotating blade to cut plaque, while rotational atherectomy uses a high-speed, diamond-coated burr to grind away calcified material. Laser atherectomy employs light energy to vaporize obstructions, and orbital atherectomy combines rotational and orbital motions for precise plaque modification. The selection of a specific device is determined by the plaque's composition and location, along with individual patient factors.

Atherectomy procedures are usually performed under imaging guidance, such as fluoroscopy, to ensure accuracy and safety. The advantages of these procedures include improved vessel patency, lower rates of restenosis, and better outcomes in more complex cases. However, there are inherent risks, such as vessel perforation or embolization, which necessitate skilled operators and careful patient selection. As advancements in cardiovascular technology continue, atherectomy devices are evolving, providing safer and more effective methods for managing atherosclerosis.

 

FutureWise Market Research has published a report that provides an insightful analysis of Atherectomy Devices Market trends that are affecting the overall market growth.

Request a Free Sample @ https://www.futurewiseresearch.com/contact.aspx?rpt=252&type=requestsample

Atherectomy Devices Market Segmentation:

By Product

  • Directional Atherectomy Systems
  • Orbital Atherectomy Systems
  • Photo-Ablative (Laser) Atherectomy Systems
  • Rotational Atherectomy Systems
  • Support Devices

By Application

  • Peripheral Vascular Applications
  • Cardiovascular Applications
  • Neurovascular Applications

By End User

  • Hospitals and Surgical Centers
  • Ambulatory Care Centers
  • Research Laboratories and Academic Institutes

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

Competitive Landscape in Atherectomy Devices Market:

  • Medtronic Plc.
  • Boston Scientific Corp.
  • Avinger Inc.
  • Koninklijke Philips N.V
  • Abbott Laboratories
  • B Braun Melsungen AG
  • Cardinal Health
  • Terumo Corporation
  • C. R. Bard, Inc.
  • Straub Medical AG.
  • Minnetronix, Inc.
  • Biomerics
  • Cardiovascular Systems
  • Biotronik
  • RA Medical Systems

Recent developments by key players in Atherectomy Devices Market:

Medtronic

In April 2025, Medtronic published data from a subgroup analysis of a systematic literature review (SLR) focused on atherectomy. This analysis assesses the safety and effectiveness of atherectomy across various patient and lesion groups, adding to the increasing body of evidence that supports atherectomy procedures.

Boston Scientific Corporation

  • Boston Scientific is promoting its Jetstream™ Atherectomy System for treating various lesion types, including calcium, plaque, and thrombus. With active aspiration technology, it minimizes the risk of distal embolization and has shown significant lumen gain in calcified lesions, as demonstrated by recent studies.
  • Boston Scientific actively participates in key conferences like TCT® 2025 and CIRSE 2025 to showcase innovations, share clinical data, and connect with healthcare professionals in interventional cardiology.

Buy now the latest version of this report: https://www.futurewiseresearch.com/checkout.aspx?ReportId=252&license=multi

**Objectives of this Study: **

  1. To provide a comprehensive analysis of the Atherectomy Devices Market By Product, By Application, By End User and By Region.
  2. To offer detailed insights into factors such as drivers, restraints, trends, and opportunities, as well as segmental and regional influences on market growth.
  3. To evaluate current market trends and forecast micro-markets, presenting overall market projections in the form of data sets and PowerPoint presentations.
  4. To predict the market size in key regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

                                                                                                                
Flexible Delivery Model:

  • We have a flexible delivery model and you can suggest changes in the scope/table of contents as per your requirement
  • The customization services offered are free of charge with the purchase of any license of the report.
  • You can directly share your requirements/changes to the current table of contents to: sales@futurewiseresearch.com